Insider · CIK 0001899977

Schneyer Mark C.

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001899977

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-06	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+14.3K sh	$17.84	+$255K	82,120
2026-08-06	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−5,000 sh	$29.00	−$145K	77,120
2026-08-06	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−9,292 sh	$29.34	−$273K	67,828
2026-08-06	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−14.3K sh	—	—	60,423
2026-08-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,849 sh	$17.84	+$104K	73,677
2026-08-05	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−5,849 sh	$29.00	−$170K	67,828
2026-08-05	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−5,849 sh	—	—	74,715
2026-05-04	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−3,506 sh	$21.79	−$76.4K	66,145
2026-05-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+6,815 sh	—	—	69,651
2026-05-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−6,815 sh	—	—	6,815
2026-04-07	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−2,709 sh	$22.20	−$60.1K	62,836
2026-04-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,276 sh	—	—	65,545
2026-04-05	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−5,276 sh	—	—	0
2026-03-26	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−3,171 sh	$21.65	−$68.7K	60,306
2026-03-26	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−37 sh	$21.72	−$803.544	60,269
2026-03-25	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−4,177 sh	$21.47	−$89.7K	57,299
2026-03-25	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+6,178 sh	—	—	63,477
2026-03-25	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−6,178 sh	—	—	12,358
2026-03-24	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+8,138 sh	—	—	61,476
2026-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−8,138 sh	—	—	24,414
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, CHIEF FINANCIAL OFFICER	AAward	+90.7K sh	—	—	90,691
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, CHIEF FINANCIAL OFFICER	AAward	+26.4K sh	—	—	26,382
2025-11-18	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−10.3K sh	$23.69	−$243K	53,338
2025-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+9,913 sh	—	—	53,687
2025-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+9,913 sh	—	—	63,600
2025-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−9,913 sh	—	—	0
2025-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−9,913 sh	—	—	0
2025-09-15	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−3,498 sh	$23.65	−$82.7K	43,447
2025-09-12	ACADACADIA PHARMACEUTICALS INCA Award	EVP, CHIEF FINANCIAL OFFICER	AAward	+6,815 sh	—	—	46,945
2025-08-18	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−22K sh	$25.18	−$554K	40,130
2025-05-16	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−2,000 sh	$25.00	−$50K	62,130
2025-05-02	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−3,498 sh	$14.60	−$51.1K	62,773
2025-05-01	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+6,815 sh	—	—	66,271
2025-05-01	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−6,815 sh	—	—	13,630
2025-04-08	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−2,708 sh	$14.82	−$40.1K	59,456
2025-04-05	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,275 sh	—	—	62,164
2025-04-05	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−5,275 sh	—	—	5,276
2025-03-26	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−3,171 sh	$17.05	−$54.1K	56,889
2025-03-25	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+6,178 sh	—	—	60,060
2025-03-25	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−6,178 sh	—	—	18,536
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, CHIEF FINANCIAL OFFICER	AAward	+111K sh	—	—	110,761
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, CHIEF FINANCIAL OFFICER	AAward	+32.6K sh	—	—	32,552
2025-02-24	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−773 sh	$19.96	−$15.4K	53,882
2025-02-23	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,353 sh	—	—	54,655
2025-02-23	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,353 sh	—	—	0
2024-11-19	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, CHIEF FINANCIAL OFFICER	SSale	−10.3K sh	$16.81	−$172K	53,302
2024-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+9,913 sh	—	—	53,648
2024-11-17	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	+9,913 sh	—	—	63,561
2024-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−9,913 sh	—	—	9,913
2024-11-17	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, CHIEF FINANCIAL OFFICER	MExercise/Conversion	−9,913 sh	—	—	9,913

Recent filings

Accepted (ET)
Aug 74
Schneyer Mark C.0001899977-26-000008
SEC(opens sec.gov)
May 54
Schneyer Mark C.0001899977-26-000007
SEC(opens sec.gov)
Apr 74
Schneyer Mark C.0001899977-26-000005
SEC(opens sec.gov)
Mar 264
Schneyer Mark C.0001899977-26-000003
SEC(opens sec.gov)

Companies

ACADIA PHARMACEUTICALS INCEVP, CHIEF FINANCIAL OFFICERACAD

Address

C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400

SAN DIEGO, CA, 92130